Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in sézary syndrome

Journal of Investigative Dermatology

Volumn 133, Issue 11, 2013, Pages 2617-2625

  Izykowska, Katarzyna ^a   Zawada, Mariola ^a   Nowicka, Karina ^a   Grabarczyk, Piotr ^b   Braun, Floriane C M ^b   Delin, Martin ^b   Möbs, Markus ^c   Beyer, Marc ^c   Sterry, Wolfram ^c   Schmidt, Christian A ^b   Przybylski, Grzegorz K ^a,b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

AIG1 GOSR1 GENE; ARTICLE; BCL2 GENE; CCDC28A IL22RA2 GENE; CHROMOSOME 6Q; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 3; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FUSION GENE; GENE DISRUPTION; GENE OVEREXPRESSION; HSPA8 GENE; HUMAN; HUMAN CELL; IL22RA2 GENE; MEDICAL DEVICE; NUCLEOTIDE SEQUENCE; ONCOGENE MYB; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SEZARY SYNDROME;

EID: 84885958420     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.188     Document Type: Article

References (33)

1. Ballif BC, Wakui K, Gajecka M et al. (2004) Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet 114:198-206 (Pubitemid 38195348)
2. Batista DA, Vonderheid EC, Hawkins A et al. (2006) Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sezary syndrome: search for recurrent chromosome abnormalities. Genes Chromosomes Cancer 45:383-91 (Pubitemid 43346770)
3. Braun FC, Grabarczyk P, Mobs M et al. (2011) Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia 25:1494-501
4. Caprini E, Cristofoletti C, Arcelli D et al. (2009) Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays. Cancer Res 69:8438-46
5. Chen W, Kalscheuer V, Tzschach A et al. (2008) Mapping translocation breakpoints by next-generation sequencing. Genome Res 18:1143-9 (Pubitemid 351931165)
6. Chen W, Ullmann R, Langnick C et al. (2010) Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing. Eur J Hum Genet 18:539-43
7. Davies L, Spiller D, White MR et al. (2011) PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells. Cell Death Dis 2:e136
8. Dumoutier L, Lejeune D, Colau D et al. (2001) Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 166:7090-5 (Pubitemid 32525578)
9. Espinet B, Salido M, Pujol RM et al. (2004) Genetic characterization of Sezary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization. Haematologica 89:165-73 (Pubitemid 38796490)
10. Feldman AL, Dogan A, Smith DI et al. (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 117:915-9
11. Fischer TC, Gellrich S, Muche JM et al. (2004) Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 122:579-86 (Pubitemid 38471321)
12. Grossmann V, Kohlmann A, Klein HU et al. (2011) Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure. Leukemia 25:671-80
13. Hwang ST, Janik JE, Jaffe ES et al. (2008) Mycosis fungoides and Sezary syndrome. Lancet 371:945-57
14. Izykowska K, Przybylski GK (2011) Genetic alterations in Sezary syndrome. Leuk Lymphoma 52:745-53
15. Lamprecht B, Kreher S, Mobs M et al. (2012) The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome. Br J Dermatol 167:240-6
16. Manfe V, Biskup E, Johansen P et al. (2012) MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53. J Invest Dermatol 132:1487-96
17. Mansour JC, Schwarz RE (2008) Molecular mechanisms for individualized cancer care. J Am Coll Surg 207:250-8
18. Mao X, Orchard G, Lillington DM et al. (2004) BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 151:546-56 (Pubitemid 39330877)
19. Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233-45 (Pubitemid 46480968)
20. Persson M, Andren Y, Mark J et al. (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 106:18740-4
21. Petit A, Ragu C, Soler G et al. (2012) Functional analysis of the NUP98-CCDC28A fusion protein. Haematologica 97:379-87
22. Poenitz N, Simon-Ackermann J, Gratchev A et al. (2005) Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Dermatology 211:84-92 (Pubitemid 41160240)
23. Prince HM, Whittaker S, Hoppe RT (2009) How I treat mycosis fungoides and Sezary syndrome. Blood 114:4337-53
24. Przybylski GK, Dik WA, Wanzeck J et al. (2005) Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11BTRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 19:201-8 (Pubitemid 40220582)
25. Przybylski GK, Dittmann K, Grabarczyk P et al. (2010) Molecular characterization of a novel chromosomal translocation t(12;14)(q23;q11.2) in T-lymphoblastic lymphoma between the T-cell receptor delta-deleting elements (TRDREC and TRAJ61) and the hypothetical gene C12orf42. Eur J Haematol 85:452-6
26. Qin JZ, Zhang CL, Kamarashev J et al. (2001) Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 98:2778-83
27. Sellers WR (2011) A blueprint for advancing genetics-based cancer therapy. Cell 147:26-31
28. Sobreira NL, Gnanakkan V, Walsh M et al. (2011) Characterization of complex chromosomal rearrangements by targeted capture and next-generation sequencing. Genome Res 21:1720-7
29. Steininger A, Mobs M, Ullmann R et al. (2011) Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med 208:1585-93
30. Stenman G, Andersson MK, Andren Y (2010) New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Cell Cycle 9:2986-95
31. Taborelli M, Tibiletti MG, Martin V et al. (2006) Chromosome band 6q deletion pattern in malignant lymphomas. Cancer Genet Cytogenet 165:106-13 (Pubitemid 43343503)
32. Talkowski ME, Ernst C, Heilbut A et al. (2011) Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet 88:469-81
33. Varley H, Di S, Scherer SW et al. (2000) Characterization of terminal deletions at 7q32 and 22q13.3 healed by De novo telomere addition. Am J Hum Genet 67:610-22 (Pubitemid 30659592)